RE:Building anticipation to achieve an optimal resultDr Rothenberg is also a Board Member of Surrozen ,and Tngo THreapeutics ,and Aulos Science ,,,
Aulos has what appears to be a very disruptive approach to treating cancer...
While I think its great that he is advising THTX I think that coming to the conclusion that he came on board because he sees certainty of success in TH 1902 is far fetch....He is getting paid for his consulting work and probably a friend pf Paul
I dont think Rothenburgh could have seen any concrete evidence of success when he joined many months ago when there were just a handful of patients enrolled in the trial....
Nice to have him as part of the consultants but I fail to see how this can be considered as sign of success.....
SPCEO1 wrote: On the presumption that there is something noteworthy in the phase 1a results, one way TH could signal that and build some anticipation among investors for those results would be to note that Dr. Rothenberg will be participating on their 4Q and full year results conference call when they send out the press release announcing the date of the release and call.
Of course, what they have to share might not justify his presence on the call but let's hope it does.